A single institutional clinical outcome for stages III and IV ovarian cancer patients treated with dose‐dense TC therapy in the frontline or first platinum‐sensitive relapse setting
Kotaro Sueoka(Yamaguchi University), Norihiro Sugino(Yamaguchi University), Isao Tamura(Yamaguchi University), Toshiaki Taketani(Yamaguchi University), Maki Okada(Yamaguchi University), Tetsuro Tamehisa(Yamaguchi University), Takahiro Sakai(Japanese Red Cross Society, Japan), Takuya Kajimura(Yamaguchi University)
Cited by 1
Related Papers
Aryne-based strategy in the total synthesis of naturally occurring polycyclic compounds
|Chemical Society Reviews|2018|293
Some Properties of the Products of Reaction of Tadpole Collagenase with Collagen<sup>*</sup>
|Biochemistry|1967|246
Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation
|Cancer|2001|120
Mouse inter-subspecific consomic strains for genetic dissection of quantitative complex traits
|Genome Research|2008|93
Melatonin protects the integrity of granulosa cells by reducing oxidative stress in nuclei, mitochondria, and plasma membranes in mice
|Journal of Reproduction and Development|2014|87